Speciality
Spotlight

 




           

Clinical Pharmacology

       

     





Drug
Absorption

   

  • P.J.A.
    Yeates & S.H.L. Thomas (Wolfson Unit of Clinical
    Pharmacology, University of Newcastle, UK)

    Effectiveness
    of delayed activated charcoal administration in
    simulated paracetamol (acetaminophen) overdose.

    Br.J.Clin
    Pharmacol, 49, 11-14.

      

    Summary
    : Oral activated charcoal is used to treat drug
    overdose and is effective at reducing drug
    absorption when given within 1 hour of drug
    ingestion. In
    most cases of drug overdose, the delay in
    administering activated charcoal is more than 1
    hour. This study has investigated the efficacy of activated charcoal at
    preventing paracetamol absorption after simulated
    overdose (3 gms. Paracetamol tablets in healthy
    volunteers) when administration was delayed between
    1 and 4 hours. Dose
    of activated charcoal used was 50 gms.
    Plasma paracetamol concentrations were
    measured using HPLC.

      

    Activated
    charcoal significantly reduced paracetamol AUC (4,9
    hrs) when administered after 1 hr, but
    administration after 2 or 4 hrs did not have
    significant effect. Results
    in healthy volunteers cannot be directly
    extrapolated to patients of overdose, but they
    provide no evidence of efficacy for activated
    charcoal when administered after an interval of more
    than 2 hrs.

      

  • Henrik
    Toft Sorensen, Gunnar Lauge Nielsen, et al
    (Department of 
    Internal Medicine V, 
    Aarhus University Hospital Aarhus, Denmark)

    Birth
    outcome following maternal use of metoclopramide

    Br.J.Clin.Pharmacol,
    49, 264-268.

      

    Summary:
    Metoclopramide is an antiemetic drug used widely
    during pregnancy for nausea and vomiting.
    As its use is widespread, adverse effects on
    infants would have major public health implications.

      

    This
    study has been conducted in Sweden, using the
    Pharmaco-Epidemiological Prescription Database.
    Three hundred and nine women who had
    prescriptions for metoclopramide from January to
    December 1996 were included in the study.
    Information on malformations, birth-weight,
    preterm deliveries and stillbirths were compared
    with controls (13,327 women) who did not receive
    prescriptions of any kind during pregnancy.

      

    The
    authors could not document any association between
    the use of metoclopramide during pregnancy and
    adverse pregnancy outcome.
    As this is limited study, further research is
    required.

      

  • Jean
    Frederic Westphal (Unit
    of Geriatric Medicine, France
    )

    Macrolide
    – induced clinically relevant drug interactions with
    cytochrome P-450a
    (cyp)
    3A4: an update focused on clarithromycin,
    azithromycin and dirithromycin.

    Br.
    Jr.Cl. Pharmacology, oct.2000, 50(4), 285-295

      

    Summary: Erythromycin binds strongly,
    clarithromycin to a lesser extent and azithromycin
    the least to the cytochrome CYP 3A4, which is
    involved in oxidative phase of biotransformation of
    drugs. Hence,
    erythromycin produces maximum drug interactions and
    azithromycin and dirithromycin the least drug
    interactions.

       

    Clinically
    relevant drug-interactions with benzodiazepines,
    neuroleptics, HMG CoA reductase inhibitors,
    anti-arrhythmic agents and warfarin are described.



       



  
 



 

     

Speciality Spotlight

 

           
Clinical Pharmacology
       

     

Drug Absorption
   

  • P.J.A. Yeates & S.H.L. Thomas (Wolfson Unit of Clinical Pharmacology, University of Newcastle, UK)
    Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose.
    Br.J.Clin Pharmacol, 49, 11-14.
      
    Summary : Oral activated charcoal is used to treat drug overdose and is effective at reducing drug absorption when given within 1 hour of drug ingestion. In most cases of drug overdose, the delay in administering activated charcoal is more than 1 hour. This study has investigated the efficacy of activated charcoal at preventing paracetamol absorption after simulated overdose (3 gms. Paracetamol tablets in healthy volunteers) when administration was delayed between 1 and 4 hours. Dose of activated charcoal used was 50 gms. Plasma paracetamol concentrations were measured using HPLC.
      
    Activated charcoal significantly reduced paracetamol AUC (4,9 hrs) when administered after 1 hr, but administration after 2 or 4 hrs did not have significant effect. Results in healthy volunteers cannot be directly extrapolated to patients of overdose, but they provide no evidence of efficacy for activated charcoal when administered after an interval of more than 2 hrs.
      

  • Henrik Toft Sorensen, Gunnar Lauge Nielsen, et al (Department of  Internal Medicine V,  Aarhus University Hospital Aarhus, Denmark)
    Birth outcome following maternal use of metoclopramide
    Br.J.Clin.Pharmacol, 49, 264-268.
      
    Summary: Metoclopramide is an antiemetic drug used widely during pregnancy for nausea and vomiting. As its use is widespread, adverse effects on infants would have major public health implications.
      
    This study has been conducted in Sweden, using the Pharmaco-Epidemiological Prescription Database. Three hundred and nine women who had prescriptions for metoclopramide from January to December 1996 were included in the study. Information on malformations, birth-weight, preterm deliveries and stillbirths were compared with controls (13,327 women) who did not receive prescriptions of any kind during pregnancy.
      
    The authors could not document any association between the use of metoclopramide during pregnancy and adverse pregnancy outcome. As this is limited study, further research is required.
      

  • Jean Frederic Westphal (Unit of Geriatric Medicine, France)
    Macrolide – induced clinically relevant drug interactions with cytochrome P-450a (cyp) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.
    Br. Jr.Cl. Pharmacology, oct.2000, 50(4), 285-295
      
    Summary: Erythromycin binds strongly, clarithromycin to a lesser extent and azithromycin the least to the cytochrome CYP 3A4, which is involved in oxidative phase of biotransformation of drugs. Hence, erythromycin produces maximum drug interactions and azithromycin and dirithromycin the least drug interactions.
       
    Clinically relevant drug-interactions with benzodiazepines, neuroleptics, HMG CoA reductase inhibitors, anti-arrhythmic agents and warfarin are described.

       

    

 

By |2022-07-20T16:44:09+00:00July 20, 2022|Uncategorized|Comments Off on Drug Absorption

About the Author: